Cytochrome Oxidase Deficiency in Alzheimer's Disease a

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Annals of the New York Academy of Sciences

• Publication date

  1991-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/j.1749-6632.1991.tb00191.xPMID 1663716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 1-methyl-4-phenylpyridinium (MPP[+]) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles

  1993cited by this paper
• Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation.

  1990cited by this paper
• Cytochrome oxidase deficiency in Alzheimer's disease

  1990cited by this paper
• Rapid shift in genotype of human mitochondrial DNA in a family with Leber's hereditary optic neuropathy.

  1990cited by this paper
• Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation.

  1990cited by this paper
• 1-Methyl-4-phenylpyridinium (MPP+) induces NADH-dependent superoxide formation and enhances NADH-dependent lipid peroxidation in bovine heart submitochondrial particles.

  1990cited by this paper
• Abnormalities of the electron transport chain in idiopathic parkinson's disease

  1989cited by this paper
• Genetic heterogeneity and mitochondrial DNA heteroplasmy in Leber's hereditary optic neuropathy.

  1989cited by this paper
• Genetic heterogeneity in Leber hereditary optic neuroretinopathy revealed by mitochondrial DNA polymorphism.

  1989cited by this paper
• A defect in mitochondrial electron-transport activity (NADH-coenzyme Q oxidoreductase) in Leber's hereditary optic neuropathy.

  1989cited by this paper
• A mitochondrial DNA mutation as a cause of Leber's hereditary optic neuropathy.

  1989cited by this paper
• Oxygen-based free radical generation by ferrous ions and deferoxamine.

  1989cited by this paper
• Brain cytochrome oxidase: purification, antibody production, and immunohistochemical/histochemical correlations in the CNS

  1989cited by this paper
• Mitochondrial DNA mutation associated with Leber's hereditary optic neuropathy.

  1988cited by this paper
• Myxothiazol resistance in human mitochondria.

  1988cited by this paper
• DNA damage and oxygen radical toxicity.

  1988cited by this paper
• Energy metabolism in disorders of the nervous system.

  1988cited by this paper
• Inhibition of mitochondrial respiration by analogs of 4-phenylpyridine and 1-methyl-4-phenylpyridinium cation (MPP+), the neurotoxic metabolite of MPTP.

  1987cited by this paper
• Energy-dependent uptake of N-methyl-4-phenylpyridinium, the neurotoxic metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, by mitochondria.

  1986cited by this paper
• Studies on the Neurotoxicity of 1‐Methyl‐4‐Phenyl‐1,2,3,6‐Tetrahydropyridine: Inhibition of NAD‐Linked Substrate Oxidation by Its Metabolite, 1‐Methyl‐4‐Phenylpyridinium

  1986cited by this paper
• Uptake of the neurotoxin 1-methyl-4-phenylpyridine (MPP+) by mitochondria and its relation to the inhibition of the mitochondrial oxidation of NAD+-linked substrates by MPP+.

  1986cited by this paper
• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

  1985cited by this paper
• 1-Methyl-4-phenyl-pyridinium-induced inhibition of nicotinamide adenosine dinucleotide cytochrome c reductase.

  1985cited by this paper
• Iron-catalyzed hydroxyl radical formation. Stringent requirement for free iron coordination site.

  1984cited by this paper
• Progressive poliodystrophy (Alpers' disease) with a defect in cytochrome aa3 in muscle: a report of two unrelated patients.

  1983cited by this paper
• Progressive poliodystrophy (alpers') disease) with a defect in cytochrome in muscle: a report of two unrelated patients

  1983cited by this paper
• Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis.

  1983cited by this paper
• Separation of mammalian cytochrome c oxidase into 13 polypeptides by a sodium dodecyl sulfate-gel electrophoretic procedure.

  1983cited by this paper
• Kinetic and structural differences between cytochrome c oxidases from beef liver and heart.

  1982cited by this paper
• Hydrogen peroxide causes the fatal injury to human fibroblasts exposed to oxygen radicals.

  1981cited by this paper
• Maternal inheritance of mitochondrial DNA polymorphisms in cultured human fibroblasts

  1981cited by this paper
• Sequence and organization of the human mitochondrial genome

  1981influential reference
• Maternal inheritance of human mitochondrial DNA.

  1980cited by this paper
• Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria.

  1980cited by this paper
• Impairment of retention of avoidance responses in rats by posttraining diethyldithiocarbamate

  1977cited by this paper
• Maternal inheritance of mammalian mitochondrial DNA

  1974cited by this paper
• Maternal and cytoplasmic inheritance of mitochondrial DNA in Xenopus.

  1972cited by this paper
• Leber's optic atrophy: a possible example of vertical transmission of a slow virus in man.

  1970cited by this paper
• A new manifestation of Leber's disease and a new explanation for the agency responsible for its unusual pattern of inheritance.

  1970cited by this paper
• Putnam Anniversary Volume

  1912cited by this paper

• Neurodegeneration and aging: pathophysiology, diagnosis, and therapeutic targets

  2025cites this paper
• A blood based mitochondrial functional index biomarker for Alzheimer's disease

  2025cites this paper
• A Blood Based Mitochondrial Functional Index Biomarker for Alzheimers Disease

  2025cites this paper
• Intrinsic aerobic capacity modulates Alzheimer’s disease pathological hallmarks, brain mitochondrial function and proteome during aging

  2024cites this paper
• Photobiomodulation improves depression symptoms: a systematic review and meta-analysis of randomized controlled trials

  2024cites this paper
• Recent Advances in Mitochondrial Pyruvate Carrier Inhibitors

  2024cites this paper
• Mitochondrial mechanisms in Alzheimer's disease: quest for therapeutics.

  2023cites this paper
• Editorial: Systemic implications of Alzheimer's disease

  2023cites this paper
• Mitochondria in Health, Disease, and Ageing.

  2023cites this paper
• [Beneficial effects of ketogenic diet for Alzheimer's disease management].

  2023cites this paper
• Editorial: Metabolism in Alzheimer's Disease

  2022cites this paper
• Mitochondrial function and Aβ in Alzheimer's disease postmortem brain.

  2022cites this paper
• Disentangling Mitochondria in Alzheimer’s Disease

  2021cites this paper
• Apolipoprotein E and Alzheimer's disease

  2021cites this paper
• Heme metabolism, mitochondria, and complex I in neuropsychiatric disorders

  2020cites this paper
• Mitophagy and the Brain

  2020cites this paper
• Mitochondrial Dysfunction and Stress Responses in Alzheimer’s Disease

  2019cites this paper
• Cause or casualty: The role of mitochondrial DNA in aging and age-associated disease.

  2019cites this paper
• Alzheimer's Disease: Recent Concepts on the Relation of Mitochondrial Disturbances, Excitotoxicity, Neuroinflammation, and Kynurenines.

  2018cites this paper
• Loss of the Mitochondrial Fatty Acid β-Oxidation Protein Medium-Chain Acyl-Coenzyme A Dehydrogenase Disrupts Oxidative Phosphorylation Protein Complex Stability and Function

  2018cites this paper
• Exploring and exploiting the connection between mitochondria and the virulence of human pathogenic fungi

  2018cites this paper
• The protective role of plant biophenols in mechanisms of Alzheimer's disease.

  2017cites this paper
• Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer’s Disease

  2017cites this paper
• Peripheral adenosine levels in euthymic patients with bipolar disorder.

  2016influential citation
• Oncostatic-Cytoprotective Effect of Melatonin and Other Bioactive Molecules: A Common Target in Mitochondrial Respiration

  2016cites this paper
• Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease

  2016cites this paper
• Transcranial Laser Stimulation as Neuroenhancement for Attention Bias Modification in Adults with Elevated Depression Symptoms.

  2016cites this paper
• Controlled and Impaired Mitochondrial Quality in Neurons: Molecular Physiology and Prospective Pharmacology.

  2015cites this paper
• Calorie restriction does not restore brain mitochondrial function in P301L tau mice, but it does decrease mitochondrial F0F1-ATPase activity.

  2015cites this paper
• Platelets in Alzheimer’s Disease

  2015cites this paper
• Herpes Simplex Virus Type 1 and Other Pathogens are Key Causative Factors in Sporadic Alzheimer’s Disease

  2015cites this paper
• Pharmacology of Olive Biophenols in Alzheimer's Disease Prevention and Treatment

  2015cites this paper
• Molecular and Cellular Neuroscience

  2015cites this paper
• The Neuroprotective Effects of Decursin Isolated from Angelica gigas Nakai Against Amyloid β-Protein-Induced Apoptosis in PC 12 Cells via a Mitochondria-Related Caspase Pathway

  2015cites this paper
• Melatonin’s Mitochondrial Protective Role in Alzheimer’s Mice: Role of Melatonin Receptors

  2014cites this paper
• Targeting the Prodromal Stage of Alzheimer’s Disease: Bioenergetic and Mitochondrial Opportunities

  2014cites this paper
• Mitochondrial Alterations near Amyloid Plaques in an Alzheimer's Disease Mouse Model

  2013cites this paper
• Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease.

  2013cites this paper
• Nuclear and mitochondrial DNA oxidation in Alzheimer's disease

  2012cites this paper
• Abnormal interaction of VDAC 1 with amyloid beta and phosphorylated tau causes mitochondrial dysfunction in Alzheimer ’ s disease

  2012cites this paper
• Estrogen regulation of mitochondrial bioenergetics: implications for prevention of Alzheimer's disease.

  2012cites this paper
• Targeting mitochondrial bioenergetics for Alzheimer's prevention and treatment.

  2011cites this paper
• Emerging roles of pathogens in Alzheimer disease

  2011cites this paper
• Amyloid-Beta Interaction with Mitochondria

  2011cites this paper
• Long-term electromagnetic field treatment enhances brain mitochondrial function of both Alzheimer's transgenic mice and normal mice: a mechanism for electromagnetic field-induced cognitive benefit?

  2011cites this paper
• Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction

  2011cites this paper
• Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

  2011cites this paper
• Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling

  2011cites this paper
• Mitochondrial autophagy in neural function, neurodegenerative disease, neuron cell death, and aging.

  2011cites this paper
• Mitochondrial dysfunction and Alzheimer's disease.

  2011cites this paper
• Mitochondrial trafficking of APP and alpha synuclein: Relevance to mitochondrial dysfunction in Alzheimer's and Parkinson's diseases.

  2010cites this paper
• A Synergistic Dysfunction of Mitochondrial Fission/Fusion Dynamics and Mitophagy in Alzheimer's Disease

  2010cites this paper
• Mitochondrial quality control and neurological disease: an emerging connection

  2010cites this paper
• Mitochondrial Amyloid-β Levels are Associated with the Extent of Mitochondrial Dysfunction in Different Brain Regions and the Degree of Cognitive Impairment in Alzheimer's Transgenic Mice

  2010cites this paper
• Biogenesis and regulation of microRNA: implication in Alzheimer’s disease

  2010cites this paper
• Cell cycle and cell death in disease: past, present and future

  2010cites this paper
• Genetic determinants at the interface of cancer and neurodegenerative disease

  2010cites this paper
• Role of Mitochondrial Amyloid-β in Alzheimer's Disease

  2010cites this paper
• Mitochondria, calcium and cell death: a deadly triad in neurodegeneration.

  2009cites this paper
• Creatine and Its Potential Therapeutic Value for Targeting Cellular Energy Impairment in Neurodegenerative Diseases

  2008cites this paper
• A new treatment regime for sodium azide to evoke experimental Alzheimer's disease for pharmacological screening

  2008cites this paper
• Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.

  2007cites this paper
• Mitochondrial Translocation of Amyloid Precursor Protein and its Cleaved Products: Relevance to Mitochondrial Dysfunction in Alzheimer's Disease

  2007cites this paper
• Enhanced apoptosis, oxidative stress and mitochondrial dysfunction in lymphocytes as potential biomarkers for Alzheimer's disease.

  2007cites this paper
• Amyloid Precursor Protein and Mitochondrial Dysfunction in Alzheimer's Disease

  2007cites this paper
• Neurotoxic effects of repetitive inhibition of oxidative phosphorylation in young adults surfacing with deficits of spatial learning in old age.

  2007cites this paper
• Accumulation of Amyloid Precursor Protein in the Mitochondrial Import Channels of Human Alzheimer’s Disease Brain Is Associated with Mitochondrial Dysfunction

  2006cites this paper
• Possible peripheral markers for chronic aluminium toxicity in Wistar rats

  2006cites this paper
• The Creatine Kinase/Creatine Connection to Alzheimer's Disease: CK Inactivation, APP-CK Complexes, and Focal Creatine Deposits

  2006cites this paper
• Mitochondrial dysfunction induced by disease relevant AβPP and tau protein mutations

  2006cites this paper
• Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release

  2005cites this paper
• Mitochondrial alterations Alzheimer's disease

  2004cites this paper
• Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells

  2003cites this paper
• Inhibition of energy metabolism down-regulates the Alzheimer related presenilin 2 gene

  2003cites this paper
• State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia

  2002cites this paper
• Mitochondria in Alzheimer's disease.

  2002cites this paper
• Ammonia and Alzheimer's disease.

  2002cites this paper
• Mitochondrial oxidative stress and metabolic alterations in neurodegenerative disorders

  2001cites this paper
• Existe relaciÓn entre la enfermedad de Alzheimer y defectos en el ADN mitocondrial

  2001cites this paper
• Acceleration of phosphatidylcholine synthesis and breakdown by inhibitors of mitochondrial function in neuronal cells: a model of the membrane defect of Alzheimer's disease.

  2000cites this paper
• The frequency of point mutations in mitochondrial DNA is elevated in the Alzheimer's brain.

  2000cites this paper
• Histoenzymology of Oxidases and Dehydrogenases in Peripheral Blood Lymphocytes and Monocytes for the Study of Mitochondrial Oxidative Phosphorylation

  2000cites this paper
• Chapter 9 The Role of Mitochondrial Genome Mutations in Neurodegenerative Disease

  1999cites this paper
• The olfactory bulb in Alzheimer’s disease

  1998cites this paper
• Mitochondrial DNA Mutations in Aging, Disease and Cancer

  1998cites this paper
• Expression of copper trafficking genes in the mouse brain

  1998cites this paper
• Cytochrome Oxidase Inhibition In Alzheimer’s Disease

  1998cites this paper
• BRAIN CYTOCHROME OXIDASE ACTIVITY AND HOW IT RELATES TO THE PATHOPHYSIOLOGY OF MEMORY AND ALZHEIMER'S DISEASE

  1998cites this paper
• Quantitative cytochemistry of cytochrome oxidase and cellular morphometry of the human inferior colliculus in control and Alzheimer's patients.

  1997cites this paper
• An ammonia hypothesis of Alzheimer disease.

  1997cites this paper
• Calcium Homeostasis and Reactive Oxygen Species Production in Cells Transformed by Mitochondria from Individuals with Sporadic Alzheimer’s Disease

  1997cites this paper
• Association of the mitochondrial tRNAA4336G mutation with Alzheimer's and Parkinson's diseases

  1997cites this paper
• Molecular Neurobiology of Alzheimer's Disease (Syndrome?)

  1997cites this paper
• Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases.

  1997cites this paper
• Cytochrome C Oxidase in Alzheimer's Disease Brain

  1995cites this paper
• The Relation of Oxidative Stress and Hyperexcitation to Neurological Disease

  1995cites this paper
• Frontal lobe phosphorus metabolism and neuropsychological function in aging and in alzheimer's disease

  1995cites this paper
• Changes of mitochondrial cytochrome c oxidase and FoF1 ATP synthase subunits in rat cerebral cortex during aging

  1995cites this paper
• Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts.

  1994cites this paper
• Peripheral Markers and Diagnostic Criteria in Alzheimer's Disease: Critical Evaluations

  1994cites this paper